Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
OTC:GZPHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
OTC:GZPHF
|
CN |
|
A
|
Autoliv Inc
DUS:LIV
|
SE |
|
Zeda Ltd
F:LJ0
|
ZA |
|
P
|
Powszechny Zaklad Ubezpieczen SA
XMUN:7PZ
|
PL |
|
Safestore Holdings PLC
F:IHF0
|
UK |
|
N
|
Navios Maritime Partners LP
NYSE:NMM
|
GR |
|
S
|
Sats ASA
OSE:SATS
|
NO |
|
AML3D Ltd
ASX:AL3
|
AU |
|
D
|
Dinero Ventures Ltd
XTSX:DNO
|
CA |
|
C
|
Chesnara PLC
OTC:CSNRF
|
UK |
|
H
|
Hiremii Ltd
ASX:HMI
|
AU |
|
Fernhill Corp
OTC:FERN
|
US |
|
Adslot Ltd
ASX:ADS
|
AU |
|
Hapvida Participacoes e Investimentos SA
OTC:HAPVY
|
BR |
|
S
|
Sixt SE
DUS:SIX2
|
DE |
|
Enstar Group Ltd
F:48R
|
BM |
Bankruptcy Probability
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
31.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
McKesson Corp
NYSE:MCK
|
104.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
61.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
54.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
29.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
59.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
46.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
46.9B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Galenica AG
SIX:GALE
|
4.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
4.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has total debt of 17.1B CNY. This includes both short-term (11.8B CNY) and long-term (5.2B CNY) debt.
You can find a full breakdown on its Balance Sheet.